Trade secret: A pharma futurist keynote speaker is someone who analyzes trends and innovations to help predict the future landscape of the pharmaceutical and biotechnology industries. Core attributes of being a working professional in the space are:
- Tracking cutting-edge research – Staying on top of the latest developments in drug discovery, biotechnology, genomics, nanotechnology, and other scientific fields that pharma futurist keynote speakers say could impact new medication development.
- Monitoring tech shifts – Keeping tabs on how emerging technologies like AI, robotics, 3D printing, wearables, and digital therapeutics could transform drug design, manufacturing, clinical trials, and delivery.
- Evaluating marketplace dynamics – Assessing ongoing shifts in demographics, healthcare access, insurance, regulations, patent expirations, and competition from generics and biosimilars that pharma futurist keynote speakers see affecting industry strategy.
- Forecasting trends – Using data, pattern analysis, and human judgement to predict the future direction of things like personalized medicine, biologics, OTC treatments, drug pricing, and healthcare consumption.
- Speculating outcomes – Developing likely scenarios of how major events like a pandemic or major new breakthrough could impact pharma and biotech. Scenario planning as a pharma futurist keynote speaker helps companies strategize.
- Providing vision – Sharing insights with company leaders on how to navigate future disruptions and opportunities in areas like R&D, partnerships, regulations, drug portfolios, and new roles for pharma companies.
- Informing investments – Guiding investment decisions as a pharma futurist keynote speaker by advising on potential new markets, tech breakthroughs, and innovations pharma firms could capitalize on for the future.
The most frequently utilized skill of a pharma futurist is using their deep industry knowledge along with data, analysis and creativity to see ahead on the horizon and help firms proactively prepare for coming developments.